Seed · Biotech · Zurich, Switzerland · Founded 2020 · 10–50 employees
Molecule is a decentralized biotech protocol that revolutionizes scientific research funding through blockchain technology and IP-NFTs. Founded by Paul Kohlhaas and Tyler Golato in 2020, the company enables researchers to tokenize intellectual property and secure funding from decentralized communities. Their platform has facilitated over $70 million in value across leading DeSci DAOs like VitaDAO, which has funded longevity research projects including collaborations with Newcastle University that went from proposal to funding in just three weeks. The company recently launched BIO Protocol as a financial layer for the entire DeSci ecosystem, with eight specialized BioDAOs collectively raising over $30 million and deploying $7.2 million into scientific projects. Notable validation includes investment from Pfizer Ventures in their partner VitaDAO and a recent $6.9 million funding round led by Maelstrom Fund.